CUE BIOPHARMA INC (CUE) Stock Cash Flow
NASDAQ:CUE - Nasdaq - US22978P1066 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -40.58M | -40.67M | -50.73M | -53.01M | -44.16M | |||
| Depreciation Amortization | 399.00K | 397.00K | 556.00K | 920.00K | 1.26M | |||
| Change In Working Capital | -2.94M | -5.02M | -1.36M | 750.00K | -4.49M | |||
| Interest Paid | 550.00K | 669.00K | 1.00M | 570.00K | N/A | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 8.40M | 8.97M | 11.58M | 9.53M | 8.56M | |||
| OPERATING CASH FLOW | -34.72M | -36.33M | -39.96M | -41.81M | -38.84M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -161.00K | -66.00K | 0.00 | -170.00K | -910.00K | |||
| Other Investing Activity | N/A | 98.00K | 25.00M | -24.44M | 10.02M | |||
| INVESTING CASH FLOW | -63.00K | 32.00K | 25.00M | -24.61M | 9.11M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -3.94M | -588.00K | 11.39M | 26.60M | N/A | |||
| Stock Issued/Repurchased | N/A | 10.83M | 473.00K | 27.20M | 19.23M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -140.00K | 0.00 | |||
| FINANCING CASH FLOW | 6.89M | 10.24M | 11.86M | 53.66M | 19.23M | |||
| CHANGE IN CASH | -27.89M | -26.05M | -3.10M | -12.76M | -10.50M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -34.72M | -36.33M | -39.96M | -41.81M | -38.84M | |||
| Capital Expenditure | -161.00K | -66.00K | 0.00 | -170.00K | -910.00K | |||
| FREE CASH FLOW | -34.88M | -36.40M | -39.96M | -41.98M | -39.75M | |||
All data in USD